C. Robert Horsburgh Jr, MD
Professor
Boston University School of Public Health
Global Health

MD, Case Western Reserve University
MS, Yale University
AB, Princeton University



Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Departments of Epidemiology, Biostatistics, Global Health and Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS, the Epidemiology of Tuberculosis and Vaccine Epidemiology. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, South Africa, Tanzania, Vietnam and the Philippines. He is a member of the Board of Directors of the International Union Against Tuberculosis and Lung Disease (IUATLD) and Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials and dissemination of best practices (www.resisttb.org).

Professor
Boston University School of Public Health
Epidemiology


Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Infectious Diseases

Professor
Boston University School of Public Health
Biostatistics




Predictors of Resistance Emergence Evaluation in Multidrug Resistant TB Patients on Treatment
11/15/2024 - 11/14/2026 (Subcontract PI)
CRDF Global National Science Fdn
OISE-9531011

RePORT India Phase II: Phase 2B: Trustee of Boston University, Medical Campus
10/01/2024 - 09/30/2026 (Subcontract PI)
CRDF Global National Science Fdn


Prevention Policy Modeling Lab (NEEMA 3)
09/30/2024 - 09/29/2025 (Subcontract PI)
Stanford University HHS CDC


Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL)
08/01/2019 - 07/31/2025 (Subcontract PI)
Boston Medical Center Corporation NIH NIAID
5R01AI147316-05

DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial
08/21/2020 - 05/31/2025 (Multi-PI)
PI: C. Robert Horsburgh Jr, MD
The Regents of the University of California, San Francisco NIH NIAID
5U01AI152980-03

Optimal targeting for individual and population-level TB prevention
12/05/2019 - 11/30/2024 (Subcontract PI)
President and Fellows of Harvard College dba Harvard T.H. Chan School of Public Health NIH NIAID
5R01AI146555-05

RePORT India Phase II
11/20/2019 - 09/30/2024 (Subcontract PI)
CRDF Global USDA Agricult ResSvc


Tuberculosis Trial Consortium
10/01/2019 - 09/30/2024 (Subcontract PI)
Veterans Affairs Medical Center of Washington DC HHS CDC
20FED2000031PSE

Prevention Policy Modeling Lab
09/30/2019 - 09/29/2024 (Subcontract PI)
Stanford University HHS CDC
5NU38PS004651

Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
08/15/2017 - 07/31/2024 (Multi-PI)
PI: C. Robert Horsburgh Jr, MD
NIH/National Institute of Allergy & Infectious Diseases
5R01AI134430-05

Showing 10 of 39 results. Show All Results

MDR-TB and HIV at RePORT Sites in India (Supplement)
08/24/2017 - 08/23/2018 (PI)
U.S. Civilian Research and Development Foundation National Science Fdn

Lifespan/Tufts/brown Center for AIDS Research (CFAR): Core K Clinical Sciences Core
07/01/2016 - 06/30/2018 (PI)
Miriam Hospital NIH-NIAID

BU Clinical HIV/AIDS Research Training Program
08/02/2010 - 07/31/2016 (PI)
NIH-NIAID
5T32AI052074-10

Boston Community Partnership Against HIV
09/30/2002 - 09/29/2005 (PI)
DHHS-Office Minority Hlth

History Of Hepatitis C Infecti
09/30/1999 - 06/30/2005 (PI)
NIH-NIDDK
5 R01 DK56410-05 & Supplement


Title


Yr Title Project-Sub Proj Pubs
2025 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 3U01AI152980-05S1
2025 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 3U01AI152980-05S2
2025 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 5U01AI152980-05
2023 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 5U01AI152980-04
2022 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 5U01AI152980-03
2021 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 5U01AI152980-02
2021 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 5R01AI134430-05
2020 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 1U01AI152980-01
2020 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 5R01AI134430-04
2020 Clinical Core 5U19AI111276-08-7772 34
Showing 10 of 59 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Rosen LV, Thielking AM, Dugdale CM, Montepiedra G, Kalk E, Kim S, LaCourse SM, Mathad JS, Freedberg KA, Horsburgh CR, Paltiel AD, Wood R, Ciaranello AL, Reddy KP. Tuberculosis Preventive Treatment for Pregnant People With HIV in South Africa: A Modeling Analysis of Clinical Benefits and Risks. Clin Infect Dis. 2025 Oct 06; 81(3):613-622. PMID: 39544107; PMCID: PMC12497950; DOI: 10.1093/cid/ciae508;
     
  2. Carwile ME, Prakash Babu S, Cintron C, Dauphinais M, Pan SJ, Thulasingam M, Horsburgh CR, Sarkar S, Hochberg NS, Sabin LL, Flynn D, Kumar B, Sinha P, Singh UB. TB stigma in India: A narrative review of types of stigma, gender differences, and potential interventions. PLOS Glob Public Health. 2025; 5(9):e0005109.View Related Profiles. PMID: 40982550; PMCID: PMC12453202; DOI: 10.1371/journal.pgph.0005109;
     
  3. Rao PS, Prakash Babu S, Ezhumalai K, Knudsen S, Ramakrishnan J, Joseph N, Cintron C, Dauphinais MR, Narasimhan PB, Salgame P, Hochberg NS, Hom DL, Heysell SK, Horsburgh CR, Ellner JJ, Sinha P, Sarkar S. Rifampin Exposure in Pregnant and Non-Pregnant Women with Tuberculosis in India. J Infect Dis. 2025 Sep 10.View Related Profiles. PMID: 40925610
     
  4. Sinha P, Karoly M, Padmapriyadarsini C, Paradkar M, Mave V, Gupte N, Gupta A, Dauphinais M, Babu SP, Gaikwad S, Cox SR, Golub J, Cintron C, Thangakunam B, Ezhumalai K, Ponnuraja C, Tornheim JA, Christopher DJ, Viswanathan V, Ellner JJ, Kornfeld H, Horsburgh CR, Bala Yogendra Shivakumar SV, Salgame P, Bollinger RC, Sarkar S, Gupte AN. Contribution of Key Comorbidities to Unfavorable Treatment Outcomes Among Adults With Drug-sensitive Pulmonary TB in India: A Prospective Cohort Analysis. Chest. 2025 Sep 10.View Related Profiles. PMID: 40939932; DOI: 10.1016/j.chest.2025.05.055;
     
  5. Niemand N, Rooney JA, Malatesta S, Rawoot N, Bouton TC, Ragan EJ, Carney T, White LF, Farhat M, Horsburgh CR, Myers B, Warren RM, Jacobson KR. Contamination rates in serially sampled sputum specimens obtained during tuberculosis treatment to capture culture conversion. Microbiol Spectr. 2025 Aug 29; e0096925.View Related Profiles. PMID: 40879468; DOI: 10.1128/spectrum.00969-25;
     
  6. Sinha P, Bhargava M, Dauphinais MR, Carwile ME, Horsburgh CR, Singh UB, Sarkar S, Bhargava A, Menzies NA. In-kind Nutritional Supplementation for Persons With Drug-susceptible Tuberculosis and Their Household Contacts Would be Cost-effective for Reducing Tuberculosis Incidence and Mortality in Jharkhand, India: A Modeling Study. Clin Infect Dis. 2025 Aug 20.View Related Profiles. PMID: 40833109
     
  7. Hyle EP, Maphosa T, Rangaraj A, Feser M, Singini GC, Shrestha P, Shroufi A, Reddy KP, Matiya E, Dambe R, Talbot VR, Chamanga R, Horsburgh CR, Weinstein MC, Nyirenda RK, Ford N, Tiam A, Phillips A, Freedberg KA. Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of care. Lancet Glob Health. 2025 Aug; 13(8):e1436-e1447. PMID: 40712615; PMCID: PMC12286912; DOI: 10.1016/S2214-109X(25)00190-1;
     
  8. Tzelios CA, Malatesta S, Carney T, White LF, Weber SE, Thomson S, Theron D, Myers B, Parry CDH, Warren RM, Horsburgh CR, Farhat MR, Jacobson KR. Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis. Clin Infect Dis. 2025 Aug 01; 81(1):167-175.View Related Profiles. PMID: 39973802; PMCID: PMC12314496; DOI: 10.1093/cid/ciae642;
     
  9. Phillips PP, Peloquin CA, Sterling TR, Mitnick CD, Horsburgh CR. Reply to Liao et al.: Optimizing Levofloxacin Dosing for MDR-TB in Low Fat-Free Mass Asian Populations. Am J Respir Crit Care Med. 2025 Jul 30. PMID: 40737625
     
  10. Dupuis GN, Dolynska M, Chiang SS, Horsburgh CR, Stagg HR, Rybak NR, Petrenko V, Jenkins HE. Risk of rifampicin resistance emergence after incomplete first-line tuberculosis treatment. Eur Respir J. 2025 Jul; 66(1).View Related Profiles. PMID: 40610055; DOI: 10.1183/13993003.00902-2025;
     
Showing 10 of 380 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 380 publications over 44 distinct years, with a maximum of 26 publications in 2024

YearPublications
19811
19833
19844
19855
19865
19875
19884
198914
19904
19916
19928
19939
19947
19958
19965
19978
19985
19997
20008
20012
20025
20034
20045
20053
20069
20073
20087
20093
201011
201114
20128
201310
20149
201512
201611
20179
201819
201915
202021
202118
20224
202311
202426
202525


Bump or spike? COVID in wastewater has experts unsurprised but wary

WBUR 12/6/2022

What to know about COVID's upswing in Massachusetts

WBUR 5/13/2022

Experts predict a COVID ‘swell’ — rather than a ‘wave’ — as cases tick upward in Mass.

WBUR 4/14/2022

What health experts expect from the next COVID phase in Massachusetts

WBUR 2/18/2022

With pediatric COVID vaccines a reality, experts reexamine whether ‘herd immunity’ is possible

WBUR 11/4/2021

Tuberculosis, Like Covid, Spreads by Breathing, Scientists Report

The New York Times 10/19/2021

COVID-19 hospitalizations have dropped over the week in Maine

WABI 10/8/2021

Baystate Business: Gaming, Dining, Covid (Radio)

Bloomberg 8/9/2021

Rate of breakthrough cases in Cape Cod cluster raises questions at CDC

The Boston Globe 7/30/2021

Provincetown COVID-19 cases climb to 882

The Boston Globe 7/29/2021

Provincetown leaders impose stricter mask rules amid COVID-19 case surge

The Boston Globe 7/25/2021

Brookline, Salem cautious as they continue local COVID-19 outdoor mask mandates (

The Boston Globe 5/3/2021

Brookline, Salem cautious as they continue local COVID-19 outdoor mask mandates

The Boston Globe 5/2/2021

Biden, public health officials face crossroads on COVID-19

The Boston Globe 3/14/2021

Texas Restaurants, Bars to Reopen at Full Capacity; Workers Not Yet Eligible for Vaccine

Food & Wine 3/3/2021

Live Blog: American life begins to return to normal, even as some fear it’s too soon.

The New York Times 3/2/2021

Texas Drops Its Virus Restrictions as a Wave of Reopenings Takes Hold

The New York Times 3/2/2021

Stadium supper, dance zones, rethinking oysters: News from around our 50 states

USA Today 3/2/2021

Moving forward in Massachusetts reopening 'careless, reckless,' Somerville mayor says

WCVB 3/1/2021

Baker pledges continued focus on vaccine equity, stands by moving forward with Mass. reopening

The Boston Globe 3/1/2021

Baker stands by loosening reopening restrictions, expects Johnson & Johnson vaccine supply later this month

The Boston Globe 3/1/2021

Baystate Business: Re-Opening Controversy (Radio)

Bloomberg 3/1/2021

‘Charlie, you’re making a big mistake’: Experts criticize state’s Monday reopening

The Boston Globe 2/28/2021

Baystate Business: Legends of Local TV (Radio)

Bloomberg 12/3/2020

COVID-19 impact from Thanksgiving travel and gatherings could be ‘precursor’ for upcoming holidays

The Boston Globe 11/29/2020

Troubling signs emerge that COVID-19 is tightening its hold on the state

The Boston Globe 11/1/2020

State reports more than 1,100 new coronavirus cases, prompting calls for a new state plan

The Boston Globe 10/24/2020

Baystate Business: Covid on the Rise (Radio)

Bloomberg 10/5/2020

Testing, schools, and a vaccine: What these experts are watching this fall amid COVID-19 in Mass

The Boston Globe 8/16/2020

Boston, Phase 3 reopening is all about safety, business owners say

The Boston Globe 7/12/2020

Scientists warn May 18 ‘still feels too early’ to begin reopening Mass.

The Boston Globe 5/12/2020

4 Bright Spots Amid the Gloom of Coronavirus

The New York Times 3/27/2020

Mass. Needs More Coronavirus Testing Now, Public Health Experts Say

WBUR 3/17/2020

Mass. increases coronavirus testing, ‘but it’s not nearly enough,’ some say

The Boston Globe 3/15/2020

2015 International Union Against Tuberculosis and Lung Disease, North American Region: Lifetime Achievement Award
2011 Boston University School of Public Health: Faculty Career Award in Research and Scholarship
2011 CDC: Excellence in Public Health Impact Award
2004 BUSPH: Teaching Award
1997 Emory University: Teaching Award
1989 US PHS Commendation Medal
1977 Lubrizol Award for Patient Care
Contact for Mentoring:

801 Massachusetts Avenue
Boston MA 02118
Google Map


Horsburgh's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department